Chronic obstructive pulmonary disease is one of the world’s leading causes of death - more than 300 million live with the ...

Currently, COPD-marketed therapy leaders include GSK’s Trelegy Ellipta, which is set to grow in sales to $2.16bn by 2033.

Early fall is when asthma flare-ups peak in the U.S., and a warming climate is bad news for sufferers: It means more ...

The Biden administration has reformed Medicare, gone after bogus drug patents and pushed pharmaceutical companies to reduce ...

Inhaled nitric oxide device INOmax Evolve DS is now available for U.S. hospitals to use on newborns, Mallinckrodt ...

Honeywell Solstice® Air can cut metered dose inhaler greenhouse gas emissions of up to 99.9% versus current propellants1 CHARLOTTE, N.C., October, 2024 – Honeywell (NASDAQ: HON) today announced a long ...

Sure, having a cold or respiratory infection can temporarily make it harder to breathe. But if excessive coughing and ...

Digital dose inhalers are crucial in enhancing medication adherence and monitoring for patients diagnosed with asthma and chronic obstructive pulmonary disease (COPD). Make Your Report Purchase ...

Patients with COPD and type 2 diabetes using SGLT2i were much less likely to have ER visits and hospitalizations related to COPD exacerbations.

With the recent expansion of our research and manufacturing capabilities, it is the perfect time to bring additional expertise to our leadership team in the critical areas of commercialization, ...